Intended for healthcare professionals

CCBYNC Open access
Corrections

Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials

BMJ 2022; 376 doi: https://doi.org/10.1136/bmj.o109 (Published 18 January 2022) Cite this as: BMJ 2022;376:o109